Bayer and Vanderbilt launch five-year partnership to accelerate innovative therapies
The partnership initially will focus on cardiovascular and kidney diseases
The partnership initially will focus on cardiovascular and kidney diseases
In Q3 FY26, Senores posted consolidated revenue of Rs. 175 crore, up 64% year-on-year.
India should explore Sustainability-Linked Incentives (SLI) targeting innovations in the 12 principles of green chemistry
Coverage has been significantly strengthened across key therapeutic categories, including anti-tubercular, anti-diabetic and anti-cancer medicines, as well as iron supplements, thereby ensuring more comprehensive standardisation of medicines used under various National Health Programmes
The primary goal of the collaboration is joint research into trending and next-generation molecules
BaseLaunch has supported 27 biotech companies across multiple modalities and indications
India has deep strengths in reverse engineering and API development, while Russia has strong capabilities in certain vaccines, biologicals, and niche therapeutic segments. Collaboration can significantly shorten R&D timelines
Subscribe To Our Newsletter & Stay Updated